Bosh sahifaNHIQ • OTCMKTS
add
NantHealth Inc
Yopilish kursi
0,00010 $
Kunlik diapazon
0,00010 $ - 0,00010 $
Bozor kapitalizatsiyasi
2,75 ming USD
Oʻrtacha hajm
187,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
NDAQ
2,42%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | sen, 2023info | Y/Y qiyosi |
---|---|---|
Daromad | 12,47 mln | — |
Joriy xarajat | 12,17 mln | — |
Sof foyda | -14,99 mln | — |
Sof foyda marjasi | -120,20 | — |
Har bir ulushga tushum | — | — |
EBITDA | -175,00 ming | — |
Amaldagi soliq stavkasi | -0,36% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | sen, 2023info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 5,82 mln | — |
Jami aktivlari | 146,48 mln | — |
Jami passivlari | 396,66 mln | — |
Umumiy kapital | -250,18 mln | — |
Tarqatilgan aksiyalar | 27,47 mln | — |
Narxi/balansdagi bahosi | -0,00 | — |
Aktivlardan daromad | -8,24% | — |
Kapitaldan daromad | -41,68% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | sen, 2023info | Y/Y qiyosi |
---|---|---|
Sof foyda | -14,99 mln | — |
Operatsiyalardan naqd pul | -7,65 mln | — |
Sarmoyadan naqd pul | 11,00 ming | — |
Moliyadan naqd pul | 7,50 mln | — |
Naqd pulning sof oʻzgarishi | -298,00 ming | — |
Boʻsh pul | -3,94 mln | — |
Haqida
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Tashkil etilgan
7-iyl, 2010
Sayt
Xodimlar soni
373